Rosen Law Firm, a global investor rights law firm, reminds purchasers of Misonix, Inc. securities (NASDAQ: MSON) from November 5, 2015 through September 14, 2016, both dates inclusive (the "Class Period") of the important November 18, 2016 lead plaintiff deadline in the class action filed by the firm. To join the Misonix class action, go to the website at http://www.rosenlegal.com/cases-953.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email email@example.com or firstname.lastname@example.org for information on the class action. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. According to the lawsuit, throughout the Class Period Misonix made false and/or misleading statements and/or failed to disclose that: (1) deficiencies existed in Misonix's internal controls over financial reporting; and (2) as a result, Defendants' statements about Misonix's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2016. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-953.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at email@example.com or firstname.lastname@example.org. Attorney Advertising. Prior results do not guarantee a similar outcome. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.